Literature DB >> 23507288

Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage.

L García-Aparicio1, J Rodo, P Palazon, O Martín, E Blázquez-Gómez, A Manzanares, N García-Smith, M Bejarano, I de Haro, J M Ribó.   

Abstract

OBJECTIVE: To present our cases of ureteral obstruction after endoscopic treatment of vesicoureteral reflux (VUR) with dextranomer/hyaluronic acid (Dx/HA). PATIENTS AND METHODS: We collected data from patients who had suffered ureteral obstruction after endoscopic treatment of VUR with Dx/HA in our institution.
RESULTS: From April 2002 to April 2011 we treated endoscopically 475 ureters with VUR, and detected 5 ureteral obstructions. Median age at reflux treatment was 39 months. Reflux grade before treatment was III in one patient and IV in four. Three ureterovesical junctions (UVJ) were blocked after a second endoscopic treatment. The median of Dx/HA injected was 1 ml (0.6-1.1). In two patients ureteral obstruction presented acutely and was treated with a ureteral stent. In the other three, the ureteral obstruction appeared gradually and was detected by ultrasound scans and MAG3 diuretic renogram; one underwent nephrectomy because of poor renal function, and the other two were treated with endoscopic dilatation of the UVJ. In all these patients both reflux and obstructions have resolved.
CONCLUSIONS: On preoperative cystography, three of the patients had a narrowed distal ureter, and probably had a refluxing and obstructive megaureter. Other causes are not clear, except for those patients with acute presentation in whom edema of the UVJ was found. Ureteral obstruction after endoscopic treatment of VUR is rare. Endoscopic intervention such as ureteral stent placement or high-pressure balloon dilatation of the UVJ has good results as a treatment of acute and delayed obstruction.
Copyright © 2013 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507288     DOI: 10.1016/j.jpurol.2013.02.007

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  10 in total

1.  Endoscopic correction of vesicoureteral reflux in children with solitary functioning kidney: insertion of a double-J stent to avoid transient ureteral obstruction.

Authors:  Seyed Hossein Hosseini Sharifi; Sorena Keihani; Behnam Nabavizadeh; Abdol-Mohammad Kajbafzadeh
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

Review 2.  Acute kidney injury due to bilateral ureteral obstruction in children.

Authors:  Daniele Bianchi; Giuseppe Vespasiani; Pierluigi Bove
Journal:  World J Nephrol       Date:  2014-11-06

3.  Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).

Authors:  L García-Aparicio; E Blázquez-Gómez; O Martin; S Pérez-Bertólez; J Arboleda; A Soria; X Tarrado
Journal:  World J Urol       Date:  2018-05-03       Impact factor: 4.226

4.  Ureteric patency after Deflux® injection for the treatment of vesicoureteric reflux in children confirmed by a novel epidural catheter-assisted endoscopic technique.

Authors:  Manabu Okawada; Soichi Shibuya; Takashi Doi; Go Miyano; Hiroyuki Koga; Geoffrey J Lane; Tadaharu Okazaki; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2015-08-19       Impact factor: 1.827

Review 5.  Vesicoureteral reflux: current management in children.

Authors:  Pedro-Jose Lopez; Soledad Celis; Francisco Reed; Ricardo Zubieta
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

6.  Late ureteral obstruction in an adult who had STING/Teflon in childhood: Should we expect an epidemic?

Authors:  Shilo Rosenberg; Amitay Lorber; Ezekiel H Landau; Dov Pode; Ofer N Gofrit; Guy Hidas; Mordechai Duvdevani; Stavros Sfoungaristos
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

7.  Postoperative ureteral obstruction after endoscopic treatment for vesicoureteral reflux.

Authors:  Jae Min Chung; Chang Soo Park; Sang Don Lee
Journal:  Korean J Urol       Date:  2015-07-01

8.  Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux.

Authors:  Ali Tekin; Ismail Yagmur; Sibel Tiryaki; Zafer Dokumcu; Ibrahim Ulman; Ali Avanoglu
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

9.  Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.

Authors:  Michelle Lightfoot; Aylin N Bilgutay; Noah Tollin; Scott Eisenberg; Jake Weiser; Leah Bryan; Edwin Smith; James Elmore; Hal Scherz; Andrew J Kirsch
Journal:  Front Pediatr       Date:  2019-09-27       Impact factor: 3.418

10.  Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.

Authors:  Stanisław Warchoł; Grażyna Krzemień; Agnieszka Szmigielska; Przemysław Bombiński; Krzysztof Toth; Teresa Dudek-Warchoł
Journal:  Cent European J Urol       Date:  2017-07-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.